4th Quarter - Report
W STRATEGIES, LLC for RAPTOR PHARMACEUTICAL CORP.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to orphan drugs and the value of innovative medicines. H.R. 3513: Prescription Drug Affordability Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Trade (domestic/foreign) TRD
Trans Pacific Partnership trade agreement, including provisions related to data exclusivity for biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
H.R. 9: Innovation Act, including changes to the Inter Partes Review process at the Patent and Trademark Office (PTO).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.